NFKB1 and neoplasm: Myricetin promotes tumor cell apoptosis by modulating certain signaling pathways, including Bcl2 (B-cell lymphoma 2), NF-κB, MAPKs (mitogen-activated protein kinases), and the Wnt/β-catenin signaling pathway [16,17,18].